A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
Recruiting · NCT06150560 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial) | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, aorta coarctation, cardiovascular disorder, congenital heart disease, heart disorder, hypertensive disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-11 | NCT06150560 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | United States | 687 |